⌘K
Loading ticker…
As of 2026-08-24, Labcorp Holdings Inc. (LH) has a 3-month relative strength percentile of 88 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 58. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 2.6%, relative volume 0.67×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
LH is in a stage 2 uptrend, week 5. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 15.5% / 24.6%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
LH appears in 1 ETF as of Jun 2026: HWSM at 0.55% weight, $15K notional.
Held by 231 ETFs · $4.0B across latest filings · largest weight 4.01% (IHF).
Top 1 by value, from SEC N-PORT-P filings dated Jun 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| HWSM | 0.55% | $15K | −0.04 pp |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Strong relative strength with attention running hot versus its own recent norm. The trend is intact but well-noticed; elevated retail attention has historically been associated with softer forward returns. Context, not a call.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LH Jan avg: 5.51% median: 7.65% win: 75% σ: 5.19% n: 4 2022-04-12 → 2026-07-31 | LH Feb avg: -0.25% median: -1.21% win: 50% σ: 5.04% n: 4 2022-04-12 → 2026-07-31 | LH Mar avg: -4.49% median: -5.72% win: 25% σ: 4.12% n: 4 2022-04-12 → 2026-07-31 | LH Apr avg: -4.20% median: -3.75% win: 20% σ: 5.92% n: 5 2022-04-12 → 2026-07-31 | LH May avg: -0.44% median: 1.27% win: 60% σ: 4.13% n: 5 2022-04-12 → 2026-07-31 | LH Jun avg: 5.21% median: 5.44% win: 80% σ: 6.72% n: 5 2022-04-12 → 2026-07-31 | LH Jul avg: 6.08% median: 5.86% win: 80% σ: 5.24% n: 5 2022-04-12 → 2026-07-31 | LH Aug avg: -0.80% median: 1.99% win: 50% σ: 9.93% n: 4 2022-04-12 → 2026-07-31 (current) | LH Sep avg: -3.00% median: -3.09% win: 25% σ: 5.05% n: 4 2022-04-12 → 2026-07-31 | LH Oct avg: -0.43% median: 0.74% win: 50% σ: 8.30% n: 4 2022-04-12 → 2026-07-31 | LH Nov avg: 7.14% median: 7.16% win: 100% σ: 1.62% n: 4 2022-04-12 → 2026-07-31 | LH Dec avg: -2.24% median: -3.54% win: 25% σ: 5.03% n: 4 2022-04-12 → 2026-07-31 |